Papaverine potently disrupted the interaction between high mobility group box 1 (HMGB1) and the receptor for advanced glycation end-products (RAGE) [49], which was thought to be the essential mechanism of its anti-proliferative action against glioblastoma cells [35,46]. The gene discussed is HMGB1; the disease is glioblastoma.